As previously performed in our lab, we first identified mixed active/inactive MS lesions with H&E (Figure 3A), LFB (Figure 3B), and CD68 (Figure 3C) staining via brightfield microscopy [22]. Here, CD68 is linked to myeloid sarcoma.